160 related articles for article (PubMed ID: 2873713)
1. Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales.
Bobon D; Troisfontaines B; Kempeneers JL; Xhenseval B; Bourdouxhe S; Mirel J; Gilson H; Toussaint C; von Frenckell R; Pedersen V
Acta Psychiatr Belg; 1986; 86(2):152-76. PubMed ID: 2873713
[TBL] [Abstract][Full Text] [Related]
2. Findings with cis-Z-clopenthixol in the treatment of acute mania and schizophrenia.
König P; Seifert T; Eberhardt G
Pharmacopsychiatry; 1986 Nov; 19(6):424-8. PubMed ID: 3797470
[TBL] [Abstract][Full Text] [Related]
3. Acute functional psychoses: treatment with zuclopenthixol dihydrochloride ('Clopixol') tablets.
Bhattacharyya SN; Ghoshal J; Sharma SK; Halstead N; John B; Launer MA; Mukherjee PK; Zigmond AS
Pharmatherapeutica; 1987; 5(1):1-8. PubMed ID: 3602019
[TBL] [Abstract][Full Text] [Related]
4. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Chouinard G; Safadi G; Beauclair L
J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
[TBL] [Abstract][Full Text] [Related]
5. [Zuclopenthixol acetate and haloperidol in acute psychoses. Results of the AMDP subgroup in a multicenter Belgian study].
Bourdouxhe S; Mirel J; Denys W; Bobon D
Acta Psychiatr Belg; 1987; 87(2):236-44. PubMed ID: 3618274
[TBL] [Abstract][Full Text] [Related]
6. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
Heikkilä L; Laitinen J; Vartiainen H
Acta Psychiatr Scand Suppl; 1981; 294():30-8. PubMed ID: 7041517
[TBL] [Abstract][Full Text] [Related]
7. Open clinical study of cis(Z)-clopenthixol.
Sechter D; Caillard V; Cuche H; Deniker P
Acta Psychiatr Scand Suppl; 1981; 294():20-4. PubMed ID: 6951393
[TBL] [Abstract][Full Text] [Related]
8. Zuclopenthixol acetate in Viscoleo--a new drug formulation. An open Nordic multicentre study of zuclopenthixol acetate in Viscoleo in patients with acute psychoses including mania and exacerbation of chronic psychoses.
Amdisen A; Nielsen MS; Dencker SJ; Fensbo C; Ahlfors UG; Gravem A; Baastrup PC; Bjerkenstedt L; Gunby B; Wiesel FA
Acta Psychiatr Scand; 1987 Jan; 75(1):99-107. PubMed ID: 2883816
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo.
Balant LP; Balant-Gorgia AE; Eisele R; Reith B; Gex-Fabry M; Garrone G
Pharmacopsychiatry; 1989 Nov; 22(6):250-4. PubMed ID: 2575763
[TBL] [Abstract][Full Text] [Related]
10. A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.
Chin CN; Hamid AR; Philip G; Ramlee T; Mahmud M; Zulkifli G; Loh CC; Zakariah MS; Norhamidah MS; Suraya Y; Roslan KA; Chandramohan P; Cheah YC; Leonard AO
Med J Malaysia; 1998 Dec; 53(4):365-71. PubMed ID: 10971979
[TBL] [Abstract][Full Text] [Related]
11. The use of oral zuclopenthixol in the treatment of functional psychotic illness.
Bereen FJ; Harte FB; Maguire J; Singh AN
Pharmatherapeutica; 1987; 5(1):62-8. PubMed ID: 3602024
[TBL] [Abstract][Full Text] [Related]
12. An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia.
Kazi HA
Pharmatherapeutica; 1986; 4(9):555-60. PubMed ID: 3763650
[TBL] [Abstract][Full Text] [Related]
13. A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients.
Heikkilä L; Karsten D; Valli K
Acta Psychiatr Scand Suppl; 1981; 294():25-9. PubMed ID: 7041516
[TBL] [Abstract][Full Text] [Related]
14. Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients.
Chakravarti SK; Muthu A; Muthu PK; Naik P; Pinto RT
Curr Med Res Opin; 1990; 12(1):58-65. PubMed ID: 1971560
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
Borsetti G; Rocco P; Spilimbergo PG; Giavedoni A; Frangiamone L; Beccaceci A; Judice A; Cisternino M; Volterra V
Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
[TBL] [Abstract][Full Text] [Related]
16. A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness.
Mann BS; Moslehuddin KS; Owen RT; Clayton AR; Rohatgi KK; Sud P; Vaddadi KS
Pharmatherapeutica; 1985; 4(6):387-92. PubMed ID: 2867559
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
Castle DJ; Udristoiu T; Kim CY; Sarosi A; Pidrman V; Omar AN; Rosales JI; Melamed Y; Isik T; Karagianis J; Treuer T
World J Biol Psychiatry; 2009; 10(1):43-53. PubMed ID: 19137460
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic treatment of oligophrenic patients. A double-blind clinical multicentre trial of cis(Z)-clopenthixol and haloperidol.
Karsten D; Kivimäki T; Linna SL; Pollari L; Turunen S
Acta Psychiatr Scand Suppl; 1981; 294():39-45. PubMed ID: 7041518
[TBL] [Abstract][Full Text] [Related]
19. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
[TBL] [Abstract][Full Text] [Related]
20. Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study.
Remvig J; Larsen H; Rask P; Skausig OB; Skov S; Strömgren LS
Pharmacopsychiatry; 1987 Jul; 20(4):147-54. PubMed ID: 3615572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
